Literature DB >> 15104378

Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium.

Nadia Osman1, Diya Adawi, Siv Ahrne, Bengt Jeppsson, Göran Molin.   

Abstract

The pathogenic mechanism of inflammatory bowel diseases is not fully understood but colonic microflora including Lactobacillus and Bifidobacterium species may affect the induction of colonic inflammation. In this study the relative efficacy of different probiotic organisms in the prevention of colitis was compared in an induced rat colitis model. Three Lactobacillus strains and two Bifidobacterium strains were fed to Sprague-Dawley rats for 7 days prior to offering the rats 5% dextran sulfate sodium (DSS) in their drinking water to induce colitis and the administration of the probiotics continued for 7 days with the DSS. Colitis severity was assessed daily using a disease activity index (DAI). Samples were collected 7 days after colitis induction for intestinal bacterial flora and bacterial translocation. The DAI decreased significantly on days 4, 5, 6, and 7 in the Lactobacillus plantarum DSM 9843, Bifidobacterium sp. 3B1, and Bifidobacterium infantis DSM 15158 groups compared to the colitis control. It decreased significantly on days 5, 6, and 7 in the Bifidobacterium infantis DSM 15158 group compared to the Lactobacillus paracaesi DSM 13434 and Lactobacillus gasseri 5B3 groups. It also decreased significantly on day 7 in the L. plantarum DSM 9843 group compared to the L. gasseri 5B3 group. Bacterial translocation to the mesenteric lymph nodes decreased significantly in all treatment groups compared to the colitis control. Enterobacteriaceae bacterial translocation to the liver decreased in all treatment groups compared to the colitis control. Administration of certain strains of Lactobacillus and Bifidobacterium significantly improves the DAI and reduces bacterial translocation, and L. plantarum DSM 9843, Bifidobacterium sp. 3B1, and Bifidobacterium infantis DSM 15158 seem to have the best effect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104378     DOI: 10.1023/b:ddas.0000017459.59088.43

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  39 in total

1.  The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats.

Authors:  Y Mao; S Nobaek; B Kasravi; D Adawi; U Stenram; G Molin; B Jeppsson
Journal:  Gastroenterology       Date:  1996-08       Impact factor: 22.682

Review 2.  Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer.

Authors:  G D'Argenio; G Mazzacca
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

3.  A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29.

Authors:  I Adlerberth; S Ahrne; M L Johansson; G Molin; L A Hanson; A E Wold
Journal:  Appl Environ Microbiol       Date:  1996-07       Impact factor: 4.792

4.  Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea.

Authors:  P Brigidi; B Vitali; E Swennen; G Bazzocchi; D Matteuzzi
Journal:  Res Microbiol       Date:  2001-10       Impact factor: 3.992

5.  Randomly amplified polymorphic DNA (RAPD) for rapid typing of Lactobacillus plantarum strains.

Authors:  M L Johansson; M Quednau; G Molin; S Ahrné
Journal:  Lett Appl Microbiol       Date:  1995-09       Impact factor: 2.858

Review 6.  Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.

Authors:  L Caradonna; L Amati; T Magrone; N M Pellegrino; E Jirillo; D Caccavo
Journal:  J Endotoxin Res       Date:  2000

7.  Effects of different probiotic strains of Lactobacillus and Bifidobacterium on bacterial translocation and liver injury in an acute liver injury model.

Authors:  D Adawi; S Ahrné; G Molin
Journal:  Int J Food Microbiol       Date:  2001-11-08       Impact factor: 5.277

8.  Colonic bacteria and bacterial translocation in experimental colitis.

Authors:  K R Gardiner; P J Erwin; N H Anderson; J G Barr; M I Halliday; B J Rowlands
Journal:  Br J Surg       Date:  1993-04       Impact factor: 6.939

9.  Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis.

Authors:  Hideki Ishikawa; Ikuko Akedo; Yoshinori Umesaki; Ryuichiro Tanaka; Akemi Imaoka; Toru Otani
Journal:  J Am Coll Nutr       Date:  2003-02       Impact factor: 3.169

10.  Colitis and colonic mucosal barrier dysfunction.

Authors:  K R Gardiner; N H Anderson; B J Rowlands; A Barbul
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

View more
  28 in total

1.  Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria.

Authors:  Benoit Foligne; Sophie Nutten; Corinne Grangette; Véronique Dennin; Denise Goudercourt; Sabine Poiret; Joelle Dewulf; Dominique Brassart; Annick Mercenier; Bruno Pot
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

Review 2.  Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.

Authors:  Dimitrios Damaskos; George Kolios
Journal:  Br J Clin Pharmacol       Date:  2008-02-12       Impact factor: 4.335

3.  Bacteria-free solution derived from Lactobacillus plantarum inhibits multiple NF-kappaB pathways and inhibits proteasome function.

Authors:  Elaine O Petrof; Erika C Claud; Jun Sun; Tatiana Abramova; Yuee Guo; Tonya S Waypa; Shu-Mei He; Yasushi Nakagawa; Eugene B Chang
Journal:  Inflamm Bowel Dis       Date:  2009-10       Impact factor: 5.325

4.  Effect of probiotics Lactobacillus acidophilus on Citrobacter rodentium colitis: the role of dendritic cells.

Authors:  Chien-Chang Chen; Cheng-Hsun Chiu; Tzou-Yien Lin; Hai Ning Shi; W Allan Walker
Journal:  Pediatr Res       Date:  2009-02       Impact factor: 3.756

5.  Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats.

Authors:  Pedro A Ruiz; Micha Hoffmann; Silke Szcesny; Michael Blaut; Dirk Haller
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

6.  Proinflammatory and anti-inflammatory cytokines present in the acute phase of experimental colitis treated with Saccharomyces boulardii.

Authors:  Nathália Nahas Grijó; Ricardo Carneiro Borra; Vera Lucia Sdepanian
Journal:  Dig Dis Sci       Date:  2009-12-09       Impact factor: 3.199

7.  Upregulation of P-glycoprotein by probiotics in intestinal epithelial cells and in the dextran sulfate sodium model of colitis in mice.

Authors:  Seema Saksena; Sonia Goyal; Geetu Raheja; Varsha Singh; Maria Akhtar; Talat M Nazir; Waddah A Alrefai; Ravinder K Gill; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-24       Impact factor: 4.052

8.  Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock.

Authors:  Misha D Luyer; Wim A Buurman; M'hamed Hadfoune; Gea Speelmans; Jan Knol; Jan A Jacobs; Cornelis H C Dejong; Aldwin J M Vriesema; Jan Willem M Greve
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

9.  Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model.

Authors:  Catherine Daniel; Sabine Poiret; Denise Goudercourt; Veronique Dennin; Gregory Leyer; Bruno Pot
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

10.  Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.

Authors:  Benoit Foligné; Sophie Nutten; Lothar Steidler; Véronique Dennin; Denise Goudercourt; Annick Mercenier; Bruno Pot
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.